Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Personalized medicine aims to tailor diagnosis and treatment based on an individual's personal genetic make-up and other predictive biomarkers-rather than a one-size fits all approach.African-Americans comprise 13.2% of the U.S. population (U.S. Census Bureau, 2014) and minorities (consisting of all but non-Hispanic Caucasian), now 37% of the U.S. population, are projected to reach closer to 57% in 2060 (U.S. Census Bureau, 2012).Indeed in coming decades minority population, including African-Americans, may exceed the Caucasian population in the U.S.Dementia, especially Alzheimer's disease (AD), has emerged as one of the biggest threats to public health and personal wellbeing among older adults.Epidemiological studies, by nature of their community sampling, have been able to study risk for AD in racially representative populations.In such studies, older African-Americans have been reported as being more likely than older Caucasians to develop AD and other dementias (Gurland et al.,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potter, G. G., Plassman, B. L., Burke, J. R., Kabeto, M. U., Langa, K. M., Llewellyn, D. J., Rogers, M. A. M., & Steffens, D. C. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.04.1234 · Cited by 209
Diagnosis and assessment of Alzheimer's disease in diverse populations
Dilworth‐Anderson, P., Hendrie, H. C., Manly, J. J., Khachaturian, A. S., & Fazio, S. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.03.001 · Cited by 139
Cited by
Diversity in Alzheimer's disease drug trials: the importance of eligibility criteria
Franzen, S., Smith, J. E., van den Berg, E., Rivera Mindt, M., van Bruchem‐Visser, R. L., Abner, E. L., Schneider, L. S., Prins, N. D., Babulal, G. M., & Papma, J. M. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12433 · Cited by 146
Gilmore-Bykovskyi, A., Croff, R., Glover, C. M., Jackson, J. D., Resendez, J., Perez, A., Zuelsdorff, M., Green-Harris, G., & Manly, J. J. (2022) · The Gerontologist · doi:10.1093/geront/gnab107 · Cited by 110
Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status
Kaplow, J., Vandijck, M., Gray, J., Kanekiyo, M., Huyck, E., Traynham, C. J., Esquivel, R., Fagan, A. M., & Luthman, J. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12000 · Cited by 81
Ashford, M. T., Raman, R., Miller, G., Donohue, M. C., Okonkwo, O. C., Mindt, M. R., Nosheny, R. L., Coker, G. A., Petersen, R. C., Aisen, P. S., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12640 · Cited by 51
Chaudhry, A., & Rizig, M. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117270 · Cited by 37
Metadata
- Authors
- Shin, J., & Doraiswamy, P. M.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-06-03
- Volume
- 8
- Pages
- 123-123
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2412500390
- Cited by
- 59
- References
- 2
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action. https://app.cochat.ai/papers/10.3389/fnagi.2016.00123
- The paper
- Shin, J., & Doraiswamy, P. M. (2016). Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2016.00123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.